More information about PIXIUM VISION

Pixium Vision was created in December 2011 by Bernard Gilly, Prof. José-Alain Sahel and several renowned scientists from prestigious academic and technology institutions in France and around the world. Pixium Vision is developing innovative Bionic Vision Restoration Systems (VRS), which are active implantable medical devices intended to treat blindness resulting from the degeneration of retinal photoreceptor cells. These devices are intended for blind patients whose optic nerve remain functional. The Bionic VRS are built around three components: • An implantable part (the retinal implant) that contains electrodes • A portable visual interface (goggles with a camera and a data transmission system) • A pocket processor. Pixium Vision is developing two VRS systems in parallel: • IRIS® (Epi-retinal system) Clinical trials are currently underway in several centers in Europe. • PRIMA (Sub-retinal system): Currently in preclinical development. Pixium Vision’s VRS are aimed at significantly improving the independence, mobility and quality of life of blind patients. The Company harnesses the rapid advances in visual processing, microelectronics / nanoelectronics, optoelectronics, neurobiology and intelligent software algorithms to develop systems that could ultimately provide blind people with a vision approaching that of a normal healthy eye. Vision: To create a world of bionic vision for those who have lost their sight. Mission: To provide best in class bionic vision restoration systems enabling the blind to regain greater autonomy and improved quality of daily living.